Escherichia coli DSM 301 is a facultative anaerobe, mesophilic, Gram-negative human pathogen of the family Enterobacteriaceae.
Gram-negative motile rod-shaped facultative anaerobe mesophilic human pathogen genome sequence
SI-ID 92094
| @ref 20215 |
Last LPSN update
2026-02-09 11:18:42 |
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Enterobacterales |
| Family Enterobacteriaceae |
| Genus Escherichia |
| Species Escherichia coli |
| Full scientific name Escherichia coli (Migula 1895) Castellani and Chalmers 1919 (Approved Lists 1980) |
| Synonyms (1) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 34 | NUTRIENT AGAR (DSMZ Medium 1) | Medium recipe at MediaDive  | Name: NUTRIENT AGAR (DSMZ Medium 1) Composition: Agar 15.0 g/l Peptone 5.0 g/l Meat extract 3.0 g/l Distilled water | ||
| 34797 | MEDIUM 3 - Columbia agar | Columbia agar (39.000 g);distilled water (1000.000 ml) | |||
| 34 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 118343 | CIP Medium 3 | Medium recipe at CIP |
| 118343 | Oxygen tolerancefacultative anaerobe |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68371 | 27613 ChEBI | amygdalin | - | builds acid from | from API 50CH acid |
| 68368 | 27613 ChEBI | amygdalin | - | fermentation | from API 20E |
| 68371 | 18305 ChEBI | arbutin | + | builds acid from | from API 50CH acid |
| 68368 | 29016 ChEBI | arginine | - | hydrolysis | from API 20E |
| 68371 | 17057 ChEBI | cellobiose | - | builds acid from | from API 50CH acid |
| 118343 | 16947 ChEBI | citrate | - | carbon source | |
| 68368 | 16947 ChEBI | citrate | - | assimilation | from API 20E |
| 68371 | 17108 ChEBI | D-arabinose | - | builds acid from | from API 50CH acid |
| 68371 | 18333 ChEBI | D-arabitol | - | builds acid from | from API 50CH acid |
| 68371 | 15824 ChEBI | D-fructose | + | builds acid from | from API 50CH acid |
| 68371 | 28847 ChEBI | D-fucose | - | builds acid from | from API 50CH acid |
| 68371 | 12936 ChEBI | D-galactose | + | builds acid from | from API 50CH acid |
| 68371 | 17634 ChEBI | D-glucose | + | builds acid from | from API 50CH acid |
| 68368 | 17634 ChEBI | D-glucose | + | fermentation | from API 20E |
| 68371 | 62318 ChEBI | D-lyxose | - | builds acid from | from API 50CH acid |
| 68371 | 16899 ChEBI | D-mannitol | + | builds acid from | from API 50CH acid |
| 68368 | 16899 ChEBI | D-mannitol | + | fermentation | from API 20E |
| 68371 | 16024 ChEBI | D-mannose | + | builds acid from | from API 50CH acid |
| 68371 | 16988 ChEBI | D-ribose | + | builds acid from | from API 50CH acid |
| 68371 | 17924 ChEBI | D-sorbitol | + | builds acid from | from API 50CH acid |
| 68371 | 16443 ChEBI | D-tagatose | - | builds acid from | from API 50CH acid |
| 68371 | 65327 ChEBI | D-xylose | + | builds acid from | from API 50CH acid |
| 68371 | 17113 ChEBI | erythritol | - | builds acid from | from API 50CH acid |
| 118343 | 4853 ChEBI | esculin | + | hydrolysis | |
| 68371 | 4853 ChEBI | esculin | + | builds acid from | from API 50CH acid |
| 68368 | 5291 ChEBI | gelatin | - | hydrolysis | from API 20E |
| 68371 | 28066 ChEBI | gentiobiose | - | builds acid from | from API 50CH acid |
| 68371 | 24265 ChEBI | gluconate | + | builds acid from | from API 50CH acid |
| 118343 | 17234 ChEBI | glucose | + | fermentation | |
| 118343 | 17234 ChEBI | glucose | + | degradation | |
| 68371 | 17754 ChEBI | glycerol | - | builds acid from | from API 50CH acid |
| 68371 | 28087 ChEBI | glycogen | - | builds acid from | from API 50CH acid |
| 68371 | 15443 ChEBI | inulin | - | builds acid from | from API 50CH acid |
| 68371 | 30849 ChEBI | L-arabinose | + | builds acid from | from API 50CH acid |
| 68368 | 30849 ChEBI | L-arabinose | + | fermentation | from API 20E |
| 68371 | 18403 ChEBI | L-arabitol | - | builds acid from | from API 50CH acid |
| 68371 | 18287 ChEBI | L-fucose | + | builds acid from | from API 50CH acid |
| 68371 | 62345 ChEBI | L-rhamnose | - | builds acid from | from API 50CH acid |
| 68368 | 62345 ChEBI | L-rhamnose | - | fermentation | from API 20E |
| 68371 | 17266 ChEBI | L-sorbose | - | builds acid from | from API 50CH acid |
| 68371 | 65328 ChEBI | L-xylose | - | builds acid from | from API 50CH acid |
| 118343 | 17716 ChEBI | lactose | + | fermentation | |
| 68371 | 17716 ChEBI | lactose | + | builds acid from | from API 50CH acid |
| 68368 | 25094 ChEBI | lysine | - | degradation | from API 20E |
| 118343 | 15792 ChEBI | malonate | - | assimilation | |
| 68371 | 17306 ChEBI | maltose | + | builds acid from | from API 50CH acid |
| 118343 | 29864 ChEBI | mannitol | + | fermentation | |
| 68371 | 6731 ChEBI | melezitose | - | builds acid from | from API 50CH acid |
| 68371 | 28053 ChEBI | melibiose | + | builds acid from | from API 50CH acid |
| 68368 | 28053 ChEBI | melibiose | + | fermentation | from API 20E |
| 68371 | 320061 ChEBI | methyl alpha-D-glucopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 43943 ChEBI | methyl alpha-D-mannoside | - | builds acid from | from API 50CH acid |
| 68371 | 74863 ChEBI | methyl beta-D-xylopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 17268 ChEBI | myo-inositol | - | builds acid from | from API 50CH acid |
| 68368 | 17268 ChEBI | myo-inositol | - | fermentation | from API 20E |
| 68371 | 59640 ChEBI | N-acetylglucosamine | + | builds acid from | from API 50CH acid |
| 118343 | 17632 ChEBI | nitrate | + | reduction | |
| 118343 | 16301 ChEBI | nitrite | + | reduction | |
| 68368 | 18257 ChEBI | ornithine | - | degradation | from API 20E |
| 68371 | Potassium 2-ketogluconate | - | builds acid from | from API 50CH acid | |
| 68371 | Potassium 5-ketogluconate | + | builds acid from | from API 50CH acid | |
| 68371 | 16634 ChEBI | raffinose | - | builds acid from | from API 50CH acid |
| 68371 | 15963 ChEBI | ribitol | - | builds acid from | from API 50CH acid |
| 118343 | 132112 ChEBI | sodium thiosulfate | - | builds gas from | |
| 68368 | 30911 ChEBI | sorbitol | + | fermentation | from API 20E |
| 68371 | 17992 ChEBI | sucrose | - | builds acid from | from API 50CH acid |
| 68368 | 17992 ChEBI | sucrose | - | fermentation | from API 20E |
| 68371 | 27082 ChEBI | trehalose | + | builds acid from | from API 50CH acid |
| 68368 | 27897 ChEBI | tryptophan | + | energy source | from API 20E |
| 68371 | 32528 ChEBI | turanose | - | builds acid from | from API 50CH acid |
| 68368 | 16199 ChEBI | urea | - | hydrolysis | from API 20E |
| 68371 | 17151 ChEBI | xylitol | - | builds acid from | from API 50CH acid |
| @ref | Metabolite | Is sensitive | Is resistant | |
|---|---|---|---|---|
| 118343 | 0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate) |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 118343 | alcohol dehydrogenase | - | 1.1.1.1 | |
| 68382 | alkaline phosphatase | + | 3.1.3.1 | from API zym |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | + | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 68368 | arginine dihydrolase | - | 3.5.3.6 | from API 20E |
| 68382 | beta-galactosidase | + | 3.2.1.23 | from API zym |
| 118343 | beta-galactosidase | + | 3.2.1.23 | |
| 68368 | beta-galactosidase | + | 3.2.1.23 | from API 20E |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 118343 | catalase | + | 1.11.1.6 | |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 68368 | cytochrome oxidase | - | 1.9.3.1 | from API 20E |
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 118343 | gelatinase | - | ||
| 68368 | gelatinase | - | from API 20E | |
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 68382 | lipase (C 14) | - | from API zym | |
| 118343 | lysine decarboxylase | - | 4.1.1.18 | |
| 68368 | lysine decarboxylase | - | 4.1.1.18 | from API 20E |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 118343 | ornithine decarboxylase | - | 4.1.1.17 | |
| 68368 | ornithine decarboxylase | - | 4.1.1.17 | from API 20E |
| 118343 | oxidase | - | ||
| 118343 | phenylalanine ammonia-lyase | + | 4.3.1.24 | |
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 118343 | tryptophan deaminase | - | ||
| 68368 | tryptophan deaminase | - | 4.1.99.1 | from API 20E |
| 118343 | urease | - | 3.5.1.5 | |
| 68368 | urease | - | 3.5.1.5 | from API 20E |
| 68382 | valine arylamidase | - | from API zym |
| @ref | ONPG | ADH (Arg) | LDC (Lys) | ODC | CIT | H2S productionH2S | URE | TDA (Trp) | IND | Acetoin production (Voges Proskauer test)VP | GEL | GLU | MAN | INO | Sor | RHA | SAC | MEL | AMY | ARA | OX | Nitrite productionNO2 | Reduction to N2N2 | MotilityMOB | Growth on MacConkey mediumMAC | OF-O | OF-F | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34 | + | - | - | - | - | - | - | - | + | - | - | + | + | - | + | - | - | + | - | + | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | |
| 34 | + | - | - | - | - | - | - | - | + | - | - | + | + | - | + | - | - | + | - | + | - | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | |
| 34 | + | - | - | - | - | - | - | - | + | - | - | + | + | - | + | - | - | + | - | + | - | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. |
| @ref | ControlQ | GLY | ERY | DARA | LARA | RIB | DXYL | LXYL | ADO | MDX | GAL | GLU | FRU | MNE | SBE | RHA | DUL | INO | MAN | SOR | MDM | MDG | NAG | AMY | ARB | ESC | SAL | CEL | MAL | LAC | MEL | SAC | TRE | INU | MLZ | RAF | AMD | GLYG | XLT | GEN | TUR | LYX | TAG | DFUC | LFUC | DARL | LARL | GNT | 2KG | 5KG | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118343 | not determinedn.d. | - | - | - | + | + | + | - | - | - | + | + | + | + | - | - | +/- | - | + | + | - | - | + | - | + | + | +/- | - | + | + | + | - | + | - | - | - | +/- | - | - | - | - | - | - | - | + | - | - | + | - | + |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 124043 | 39282_E01-4 assembly for Escherichia coli NCTC86 | complete | GCA_900699165   | 562.48255  | 8012053150  | 562 | 98.4 | |
| 124043 | ASM200770v1 assembly for Escherichia coli NCTC86 | complete | GCA_002007705 | 2923286960 | 562 | 98.28 | | |
| 124043 | NCTC86 assembly for Escherichia coli NCTC86 | scaffold | GCA_001704555 | 8011749292 | 562 | |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| A multi-strategy antimicrobial discovery approach reveals new ways to treat Chlamydia. | Olander M, Rea Vazquez D, Meier K, Singh A, Silva de Sousa A, Puertolas-Balint F, Milivojevic M, Mooij L, Fredlund J, Calpe Bosch E, Rayon Diaz M, Lundgren M, van der Wal K, Zhu S, Mateus A, Schroeder BO, Lohman JR, Sixt BS. | PLoS Biol | 10.1371/journal.pbio.3003123 | 2025 | | |
| Identification of Bioactive Peptides from Nannochloropsis oculata Using a Combination of Enzymatic Treatment, in Silico Analysis and Chemical Synthesis. | Hayes M, Mora L, Lucakova S. | Biomolecules | 10.3390/biom12121806 | 2022 | | |
| Intestinal alpha-Defensins Play a Minor Role in Modulating the Small Intestinal Microbiota Composition as Compared to Diet. | Puertolas-Balint F, Schroeder BO. | Microbiol Spectr | 10.1128/spectrum.00567-23 | 2023 | | |
| Long-Term Safety and Efficacy of Prebiotic Enriched Infant Formula-A Randomized Controlled Trial. | Neumer F, Urraca O, Alonso J, Palencia J, Varea V, Theis S, Rodriguez-Palmero M, Moreno-Munoz JA, Guarner F, Veereman G, Vandenplas Y, Campoy C. | Nutrients | 10.3390/nu13041276 | 2021 | | |
| Enzymology | Strategies for PCR based detection of Burkholderia pseudomallei DNA in paraffin wax embedded tissues. | Hagen RM, Gauthier YP, Sprague LD, Vidal DR, Zysk G, Finke EJ, Neubauer H. | Mol Pathol | 10.1136/mp.55.6.398 | 2002 | |
| Comparison of Mast Burkholderia Cepacia, Ashdown + Gentamicin, and Burkholderia Pseudomallei Selective Agar for the Selective Growth of Burkholderia Spp. | Edler C, Derschum H, Kohler M, Neubauer H, Frickmann H, Hagen RM. | Eur J Microbiol Immunol (Bp) | 10.1556/1886.2016.00037 | 2017 | | |
| Effects of tea tree oil and cefepime treatments on morphological, genetic, histopathological, immunohistochemistry, and biochemical assessments in liver and kidney of Escherichia coli infected rats. | Mansour AT, Ali AA, Almanaa TN, Altohamy DE, Ezz-Eldin RMM, Sobh MS, Abdelazim AM, Heikal HS, Mahboub HH, Aref M. | Tissue Cell | 10.1016/j.tice.2024.102581 | 2024 | | |
| Quasi-Diamond Platelet-Shaped Zinc Oxide Nanostructures Display Enhanced Antibacterial Activity. | Araiza-Campos A, Herrera-Perez G, Salas-Leiva JS, Chavez-Beltran de Rio M, Aguirre-Hernandez A, Luna-Velasco A, Salas-Leiva D, Campos-Chavez E, Tovar-Ramirez D, Romo-Chacon A, Orrantia-Borunda E, Paraguay-Delgado F. | Chembiochem | 10.1002/cbic.202300542 | 2023 | | |
| Effect of spaceflight on the phenotype and proteome of Escherichia coli. | Liu Y, Xu C, Zhao G, Wang Y, Zhu Y, Yin Y, Wang J, Li Y. | Open Life Sci | 10.1515/biol-2022-0576 | 2023 | | |
| Simulated Micro-, Lunar, and Martian Gravities on Earth-Effects on Escherichia coli Growth, Phenotype, and Sensitivity to Antibiotics. | Allen LA, Kalani AH, Estante F, Rosengren AJ, Stodieck L, Klaus D, Zea L. | Life (Basel) | 10.3390/life12091399 | 2022 | | |
| Addressing Challenges in Wildlife Rehabilitation: Antimicrobial-Resistant Bacteria from Wounds and Fractures in Wild Birds. | Sanchez-Ortiz E, Blanco Gutierrez MDM, Calvo-Fernandez C, Mencia-Gutierrez A, Pastor Tiburon N, Alvarado Piqueras A, Pablos-Tanarro A, Martin-Maldonado B. | Animals (Basel) | 10.3390/ani14081151 | 2024 | | |
| Exploration of Antibiotic Activity of Aminoglycosides, in Particular Ribostamycin Alone and in Combination With Ethylenediaminetetraacetic Acid Against Pathogenic Bacteria. | Kong J, Wu ZX, Wei L, Chen ZS, Yoganathan S. | Front Microbiol | 10.3389/fmicb.2020.01718 | 2020 | | |
| The Odyssey of the Ancestral Escherich Strain through Culture Collections: an Example of Allopatric Diversification. | Desroches M, Royer G, Roche D, Mercier-Darty M, Vallenet D, Medigue C, Bastard K, Rodriguez C, Clermont O, Denamur E, Decousser JW. | mSphere | 10.1128/msphere.00553-17 | 2018 | | |
| Coordination complexes constructed from pyrazole-acetamide and pyrazole-quinoxaline: effect of hydrogen bonding on the self-assembly process and antibacterial activity. | Chkirate K, Karrouchi K, Chakchak H, Mague JT, Radi S, Adarsh NN, Li W, Talbaoui A, Essassi EM, Garcia Y. | RSC Adv | 10.1039/d1ra09027e | 2022 | | |
| Metabolism | Biosynthesis of an antiviral compound using a stabilized phosphopentomutase by multipoint covalent immobilization. | Rivero CW, De Benedetti EC, Gallego FL, Pessela BC, Guisan JM, Trelles JA. | J Biotechnol | 10.1016/j.jbiotec.2017.03.027 | 2017 | |
| Proteome | Comparative phenotypic and proteomic analysis of colistin-exposed Pseudomonas aeruginosa. | Tran NBV, Huynh TQ, Ngo HL, Nguyen NHB, Nguyen TH, Tong TH, Trinh TTL, Nguyen VD, Pham LNM, Das PP, Lim TK, Lin Q, Nguyen TTH. | Germs | 10.18683/germs.2024.1436 | 2024 | |
| Ethnopharmacology, Phytochemistry, and Pharmacological Properties of Thymus satureioides Coss. | El Hachlafi N, Chebat A, Fikri-Benbrahim K. | Evid Based Complement Alternat Med | 10.1155/2021/6673838 | 2021 | | |
| Pathogenicity | Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii. | Barksdale SM, Hrifko EJ, Chung EM, van Hoek ML. | BMC Microbiol | 10.1186/s12866-016-0799-z | 2016 | |
| Medical Astro-Microbiology: Current Role and Future Challenges. | McDonagh F, Cormican M, Morris D, Burke L, Singh NK, Venkateswaran K, Miliotis G. | J Indian Inst Sci | 10.1007/s41745-023-00360-1 | 2023 | | |
| Biotechnology | Monte Carlo simulation as a method to determine the critical factors affecting two strains of Escherichia coli inactivation kinetics by high hydrostatic pressure. | Pina-Perez MC, Garcia-Fernandez MM, Rodrigo D, Martinez-Lopez A. | Foodborne Pathog Dis | 10.1089/fpd.2009.0383 | 2010 | |
| Ab initio Designed Antimicrobial Peptides Against Gram-Negative Bacteria. | Bobde SS, Alsaab FM, Wang G, Van Hoek ML. | Front Microbiol | 10.3389/fmicb.2021.715246 | 2021 | | |
| Pathogenicity | Inactivation of Escherichia coli (ATCC 4157) in diluted apple cider by dense-phase carbon dioxide. | Gunes G, Blum LK, Hotchkiss JH. | J Food Prot | 10.4315/0362-028x-69.1.12 | 2006 | |
| A screening for antimicrobial activities of Caribbean herbal remedies. | Luciano-Montalvo C, Boulogne I, Gavillan-Suarez J. | BMC Complement Altern Med | 10.1186/1472-6882-13-126 | 2013 | | |
| Pathogenicity | Imaging the antimicrobial mechanism(s) of cathelicidin-2. | Schneider VA, Coorens M, Ordonez SR, Tjeerdsma-van Bokhoven JL, Posthuma G, van Dijk A, Haagsman HP, Veldhuizen EJ. | Sci Rep | 10.1038/srep32948 | 2016 | |
| Enzymology | Development of a Flow Cytometry-Based Method for Rapid Detection of Escherichia coli and Shigella Spp. Using an Oligonucleotide Probe. | Xue Y, Wilkes JG, Moskal TJ, Williams AJ, Cooper WM, Nayak R, Rafii F, Buzatu DA. | PLoS One | 10.1371/journal.pone.0150038 | 2016 | |
| Pathogenicity | Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats. | Lee JH, Regmi SC, Kim JA, Cho MH, Yun H, Lee CS, Lee J. | Infect Immun | 10.1128/iai.05580-11 | 2011 | |
| Anti-aging activities of extracts from Tunisian medicinal halophytes and their aromatic constituents. | Jdey A, Falleh H, Ben Jannet S, Mkadmini Hammi K, Dauvergne X, Magne C, Ksouri R. | EXCLI J | 10.17179/excli2017-244 | 2017 | | |
| Metabolism | Effects of spaceflight and simulated microgravity on microbial growth and secondary metabolism. | Huang B, Li DG, Huang Y, Liu CT. | Mil Med Res | 10.1186/s40779-018-0162-9 | 2018 | |
| Impacts of microgravity on amino acid metabolism during spaceflight. | Dickerson BL, Sowinski R, Kreider RB, Wu G. | Exp Biol Med (Maywood) | 10.1177/15353702221139189 | 2023 | | |
| Phenotypic Changes Exhibited by E. coli Cultured in Space. | Zea L, Larsen M, Estante F, Qvortrup K, Moeller R, Dias de Oliveira S, Stodieck L, Klaus D. | Front Microbiol | 10.3389/fmicb.2017.01598 | 2017 | | |
| No Effect of Microgravity and Simulated Mars Gravity on Final Bacterial Cell Concentrations on the International Space Station: Applications to Space Bioproduction. | Santomartino R, Waajen AC, de Wit W, Nicholson N, Parmitano L, Loudon CM, Moeller R, Rettberg P, Fuchs FM, Van Houdt R, Finster K, Coninx I, Krause J, Koehler A, Caplin N, Zuijderduijn L, Zolesi V, Balsamo M, Mariani A, Pellari SS, Carubia F, Luciani G, Leys N, Doswald-Winkler J, Herova M, Wadsworth J, Everroad RC, Rattenbacher B, Demets R, Cockell CS. | Front Microbiol | 10.3389/fmicb.2020.579156 | 2020 | | |
| Transcriptome | Meta-analysis of data from spaceflight transcriptome experiments does not support the idea of a common bacterial "spaceflight response". | Morrison MD, Nicholson WL. | Sci Rep | 10.1038/s41598-018-32818-z | 2018 | |
| Antimicrobial and immunomodulatory activities of PR-39 derived peptides. | Veldhuizen EJ, Schneider VA, Agustiandari H, van Dijk A, Tjeerdsma-van Bokhoven JL, Bikker FJ, Haagsman HP. | PLoS One | 10.1371/journal.pone.0095939 | 2014 | | |
| Functional characterization of novel mutations in UL54 of ganciclovir resistant HCMV strain using structural analysis. | Malathi J, Umashankar V, Sathyabaarathi R, Muthukumaran S, Ishwarya M, Madhavan HN. | Bioinformation | 10.6026/97320630005390 | 2011 | | |
| A Molecular Genetic Basis Explaining Altered Bacterial Behavior in Space. | Zea L, Prasad N, Levy SE, Stodieck L, Jones A, Shrestha S, Klaus D. | PLoS One | 10.1371/journal.pone.0164359 | 2016 | | |
| Metabolism | Real time PCR TaqMan assays for detection of polyomaviruses KIV and WUV in clinical samples. | Bergallo M, Terlizzi ME, Astegiano S, Ciotti M, Babakir-Mina M, Perno CF, Cavallo R, Costa C. | J Virol Methods | 10.1016/j.jviromet.2009.07.016 | 2009 | |
| Enzymology | Evaluation of methods for the extraction of DNA from drinking water distribution system biofilms. | Hwang C, Ling F, Andersen GL, LeChevallier MW, Liu WT. | Microbes Environ | 10.1264/jsme2.me11132 | 2012 | |
| Phylogeny | Direct detection of nasal Staphylococcus aureus carriage via helicase-dependent isothermal amplification and chip hybridization. | Frech GC, Munns D, Jenison RD, Hicke BJ. | BMC Res Notes | 10.1186/1756-0500-5-430 | 2012 | |
| Purification and characterization of enterocin 62-6, a two-peptide bacteriocin produced by a vaginal strain of Enterococcus faecium: Potential significance in bacterial vaginosis. | Dezwaan DC, Mequio MJ, Littell JS, Allen JP, Rossbach S, Pybus V. | Microb Ecol Health Dis | 10.1080/08910600701538240 | 2007 | | |
| Necrotrophic growth of Legionella pneumophila. | Temmerman R, Vervaeren H, Noseda B, Boon N, Verstraete W. | Appl Environ Microbiol | 10.1128/aem.00070-06 | 2006 | | |
| Enzymology | Automated detection of toxigenic Clostridium difficile in clinical samples: isothermal tcdB amplification coupled to array-based detection. | Hicke B, Pasko C, Groves B, Ager E, Corpuz M, Frech G, Munns D, Smith W, Warcup A, Denys G, Ledeboer NA, Lindsey W, Owen C, Rea L, Jenison R. | J Clin Microbiol | 10.1128/jcm.00621-12 | 2012 | |
| Characterization of a monoclonal antibody that binds to an epitope on soluble bacterial peptidoglycan fragments. | Merkel GJ, Scofield BA. | Clin Diagn Lab Immunol | 10.1128/cdli.8.3.647-651.2001 | 2001 | | |
| Phylogeny | Staph ID/R: a rapid method for determining staphylococcus species identity and detecting the mecA gene directly from positive blood culture. | Pasko C, Hicke B, Dunn J, Jaeckel H, Nieuwlandt D, Weed D, Woodruff E, Zheng X, Jenison R. | J Clin Microbiol | 10.1128/jcm.05534-11 | 2012 | |
| Phylogeny | Collaborative evaluation of the Radiometer Sensititre AP80 for identification of gram-negative bacilli. | Staneck JL, Weckbach LS, Tilton RC, Zabransky RJ, Bayola-Mueller L, O'Hara CM, Miller JM. | J Clin Microbiol | 10.1128/jcm.31.5.1179-1184.1993 | 1993 | |
| Enzymology | New plate medium for facilitated differentiation of Salmonella spp. from Proteus spp. and other enteric bacteria. | Rambach A. | Appl Environ Microbiol | 10.1128/aem.56.1.301-303.1990 | 1990 | |
| Metabolism | Inhibition of vaginal lactobacilli by a bacteriocin-like inhibitor produced by Enterococcus faecium 62-6: potential significance for bacterial vaginosis. | Kelly MC, Mequio MJ, Pybus V. | Infect Dis Obstet Gynecol | 10.1080/10647440300025513 | 2003 | |
| Metabolism | Effect of probenecid on the pharmacokinetics of moxalactam. | DeSante KA, Israel KS, Brier GL, Wolny JD, Hatcher BL. | Antimicrob Agents Chemother | 10.1128/aac.21.1.58 | 1982 | |
| Enzymology | Rapid detection of members of the family Enterobacteriaceae by a monoclonal antibody. | Levasseur S, Husson MO, Leitz R, Merlin F, Laurent F, Peladan F, Drocourt JL, Leclerc H, Van Hoegaerden M. | Appl Environ Microbiol | 10.1128/aem.58.5.1524-1529.1992 | 1992 | |
| Metabolism | Moxalactam pharmacokinetics during hemodialysis. | Aronoff GR, Sloan RS, Mong SA, Luft FC, Kleit SA. | Antimicrob Agents Chemother | 10.1128/aac.19.4.575 | 1981 | |
| Rapid detection of bacteremia in mice by gas chromatography. | Mitruka BM, Jonas AM, Alexander M. | Infect Immun | 10.1128/iai.2.4.474-478.1970 | 1970 | | |
| Metabolism | Interactions of ceftazidime and tobramycin in patients with normal and impaired renal function. | Aronoff GR, Brier RA, Sloan RS, Brier ME. | Antimicrob Agents Chemother | 10.1128/aac.34.6.1139 | 1990 | |
| Evaluation of three commercial enzyme immunoassays compared with the 13C urea breath test for detection of Helicobacter pylori infection. | Marchildon PA, Ciota LM, Zamaniyan FZ, Peacock JS, Graham DY. | J Clin Microbiol | 10.1128/jcm.34.5.1147-1152.1996 | 1996 | | |
| Enzymology | A selective-differential medium for detection of Streptococcus agalactiae. | Guthrie RK, Brunson KW, Stiles JC. | Can J Comp Med Vet Sci | 1968 | | |
| Monoclonal antibodies which identify a genus-specific Listeria antigen. | Butman BT, Plank MC, Durham RJ, Mattingly JA. | Appl Environ Microbiol | 10.1128/aem.54.6.1564-1569.1988 | 1988 | | |
| Evidence of cytoplasmic membrane injury in the drying of bacteria. | WAGMAN J. | J Bacteriol | 10.1128/jb.80.4.558-564.1960 | 1960 | | |
| Enzymology | Multiple forms of bacterial hydrogenases. | Ackrell BA, Asato RN, Mower HF. | J Bacteriol | 10.1128/jb.92.4.828-838.1966 | 1966 | |
| Metabolism | Moxalactam kinetics during continuous ambulatory peritoneal dialysis after intraperitoneal administration. | Jones TE, Milne RW, Mudaliar Y, Sansom LN. | Antimicrob Agents Chemother | 10.1128/aac.28.2.293 | 1985 | |
| Metabolism | Biliary excretion of cephalosporins in rats: influence of molecular weight. | Wright WE, Line VD. | Antimicrob Agents Chemother | 10.1128/aac.17.5.842 | 1980 | |
| Phylogeny | QUANTITATIVE APPROACH TO THE STUDY OF BACTERIAL SPECIES. | LISTON J, WIEBE W, COLWELL RR. | J Bacteriol | 10.1128/jb.85.5.1061-1070.1963 | 1963 | |
| Synthesis of glutamic acid and glutamyl polypeptide by Bacillus anthracis. I. Formation of glutamic acid by transamination. | HOUSEWRIGHT RD, THORNE CB. | J Bacteriol | 10.1128/jb.60.1.89-100.1950 | 1950 | | |
| Enzymology | Mur-LH, the broad-spectrum endolysin of Lactobacillus helveticus temperate bacteriophage phi-0303. | Deutsch SM, Guezenec S, Piot M, Foster S, Lortal S. | Appl Environ Microbiol | 10.1128/aem.70.1.96-103.2004 | 2004 | |
| A Review of Medicinal Plants Used in the Management of Microbial Infections in Angola. | Tlhapi D, Malebo N, Manduna IT, Lautenschlager T, Mawunu M. | Plants (Basel) | 10.3390/plants13212991 | 2024 | | |
| Bridelia ferruginea Benth.; An ethnomedicinal, phytochemical, pharmacological and toxicological review. | Yeboah GN, Owusu FWA, Archer MA, Kyene MO, Kumadoh D, Ayertey F, Mintah SO, Atta-Adjei Junior P, Appiah AA. | Heliyon | 10.1016/j.heliyon.2022.e10366 | 2022 | | |
| Biotechnology | Probiotic potentials of Pediococuss acidilactici isolated from wara; A Nigerian unripened soft cheese. | Olajugbagbe TE, Elugbadebo OE, Omafuvbe BO. | Heliyon | 10.1016/j.heliyon.2020.e04889 | 2020 | |
| Edible Leafy Plants from Mexico as Sources of Antioxidant Compounds, and Their Nutritional, Nutraceutical and Antimicrobial Potential: A Review. | Mateos-Maces L, Chavez-Servia JL, Vera-Guzman AM, Aquino-Bolanos EN, Alba-Jimenez JE, Villagomez-Gonzalez BB. | Antioxidants (Basel) | 10.3390/antiox9060541 | 2020 | | |
| Promising role of Lawsonia inermis L. leaves extract and its nano-formulation as double treatment against aflatoxin toxicity in ulcerated-rats: Application in milk beverage. | Mohammed DM, El-Said MM, Badr AN, Abou Baker DH, Hathout AS, Sabry BA. | Heliyon | 10.1016/j.heliyon.2023.e19290 | 2023 | | |
| Pathogenicity | Validating the protective role of orange and tangerine peel extracts foramending food safety against microorganisms' contamination using molecular docking. | Sabry BA, Badr AN, Mohammed DM, Desoukey MA, Farouk A. | Heliyon | 10.1016/j.heliyon.2024.e27737 | 2024 | |
| Appraising the therapeutical potentials of Alchornea laxiflora (Benth.) Pax & K. Hoffm., an underexplored medicinal herb: A systematic review. | Jain NK, Tailang M, Kumar S, Chandrasekaran B, Alghazwani Y, Chandramoorthy HC, Kumar A, Deshpande H, Wal P, Balamurugan M, Chidambaram K. | Front Pharmacol | 10.3389/fphar.2022.958453 | 2022 | | |
| Preliminary phytochemical screening and antibacterial properties of crude stem bark extracts and fractions of Parkia biglobosa (Jacq.). | Abioye EO, Akinpelu DA, Aiyegoro OA, Adegboye MF, Oni MO, Okoh AI. | Molecules | 10.3390/molecules18078485 | 2013 | | |
| Evaluation of Antibacterial and Antifungal Properties of Alchornea laxiflora (Benth.) Pax. & Hoffman. | Akinpelu DA, Abioye EO, Aiyegoro OA, Akinpelu OF, Okoh AI. | Evid Based Complement Alternat Med | 10.1155/2015/684839 | 2015 | | |
| Metabolism | Carbon Nanoparticles Inhibit the Antimicrobial Activities of the Human Cathelicidin LL-37 through Structural Alteration. | Findlay F, Pohl J, Svoboda P, Shakamuri P, McLean K, Inglis NF, Proudfoot L, Barlow PG. | J Immunol | 10.4049/jimmunol.1700706 | 2017 | |
| Pathogenicity | Probable mechanisms of biocidal action of Cocos nucifera Husk extract and fractions on bacteria isolates. | Akinpelu DA, Alayande KA, Aiyegoro OA, Akinpelu OF, Okoh AI. | BMC Complement Altern Med | 10.1186/s12906-015-0634-3 | 2015 | |
| Emergence, Molecular Characteristics and Resistance Mechanisms of Colistin-Resistant Enterobacterales in Xuzhou, China. | Zhao S, Liang X, Li H, Sun J, Jiang F, Kang H. | Infect Drug Resist | 10.2147/idr.s526613 | 2025 | | |
| Biosurfactant Produced by Bacillus subtilis UCP 1533 Isolated from the Brazilian Semiarid Region: Characterization and Antimicrobial Potential. | Albuquerque APDC, Ferreira HS, Silva YAD, Silva RRD, Lima CVA, Sarubbo LA, Luna JM. | Microorganisms | 10.3390/microorganisms13071548 | 2025 | | |
| Investigation into scalable and efficient enterotoxigenic Escherichia coli bacteriophage production. | Wiebe KG, Cook BWM, Lightly TJ, Court DA, Theriault SS. | Sci Rep | 10.1038/s41598-024-53276-w | 2024 | | |
| Genetics | NCTC3000: a century of bacterial strain collecting leads to a rich genomic data resource. | Dicks J, Fazal MA, Oliver K, Grayson NE, Turnbull JD, Bane E, Burnett E, Deheer-Graham A, Holroyd N, Kaushal D, Keane J, Langridge G, Lomax J, McGregor H, Picton S, Quail M, Singh D, Tracey A, Korlach J, Russell JE, Alexander S, Parkhill J. | Microb Genom | 10.1099/mgen.0.000976 | 2023 | |
| Laboratory strains of Escherichia coli K-12: things are seldom what they seem. | Browning DF, Hobman JL, Busby SJW. | Microb Genom | 10.1099/mgen.0.000922 | 2023 | | |
| Genetics | Lacticaseibacillus paracasei AD22 Stress Response in Brined White Cheese Matrix: In Vitro Probiotic Profiles and Molecular Characterization. | Dishan A, Gonulalan Z. | Probiotics Antimicrob Proteins | 10.1007/s12602-024-10216-4 | 2025 | |
| 'Community evolution' - laboratory strains and pedigrees in the age of genomics. | Dorman MJ, Thomson NR. | Microbiology (Reading) | 10.1099/mic.0.000869 | 2020 | | |
| MyD88-mediated signaling in intestinal fibroblasts regulates macrophage antimicrobial defense and prevents dysbiosis in the gut. | Chulkina M, Tran H, Uribe G, McAninch SB, McAninch C, Seideneck A, He B, Lanza M, Khanipov K, Golovko G, Powell DW, Davenport ER, Pinchuk IV. | Cell Rep | 10.1016/j.celrep.2025.115553 | 2025 | | |
| Venatorbacter cucullus gen. nov sp. nov a novel bacterial predator. | Saeedi A, Cummings NJ, McLean D, Connerton IF, Connerton PL. | Sci Rep | 10.1038/s41598-021-00865-8 | 2021 | | |
| Genetics | Sequencing a piece of history: complete genome sequence of the original Escherichia coli strain. | Dunne KA, Chaudhuri RR, Rossiter AE, Beriotto I, Browning DF, Squire D, Cunningham AF, Cole JA, Loman N, Henderson IR. | Microb Genom | 10.1099/mgen.0.000106 | 2017 | |
| Occurrence of mcr Positive Strains and Molecular Characteristics of Two mcr-1 Positive Salmonella typhimurium and Escherichia coli from a Chinese Women's and Children's Hospital. | Zheng Z, Lei Y, Wang Y, Lin C, Lin J. | Infect Drug Resist | 10.2147/idr.s322686 | 2021 | | |
| Methylotrophic bacteria with cobalamin-dependent mutases in primary metabolism as potential strains for vitamin B12 production. | Dudko D, Holtmann D, Buchhaupt M. | Antonie Van Leeuwenhoek | 10.1007/s10482-022-01795-9 | 2023 | | |
| Enzymology | Two distinct gut microbial pathways contribute to meta-organismal production of phenylacetylglutamine with links to cardiovascular disease. | Zhu Y, Dwidar M, Nemet I, Buffa JA, Sangwan N, Li XS, Anderson JT, Romano KA, Fu X, Funabashi M, Wang Z, Keranahalli P, Battle S, Tittle AN, Hajjar AM, Gogonea V, Fischbach MA, DiDonato JA, Hazen SL. | Cell Host Microbe | 10.1016/j.chom.2022.11.015 | 2023 | |
| Bacterial mediated gastrointestinal inflammation. | Uronis J, Sun X. | Methods Mol Biol | 10.1007/978-1-62703-481-4_22 | 2013 | | |
| Phylogeny | Phylogenetic typing and detection of extended-spectrum beta-lactamases in Escherichia coli isolates from broiler chickens in Ahvaz, Iran. | Jafari RA, Motamedi H, Maleki E, Ghanbarpour R, Mayahi M. | Vet Res Forum | 2016 | | |
| Clinical significance of microbiota changes under the influence of psychotropic drugs. An updated narrative review. | Misera A, Loniewski I, Palma J, Kulaszynska M, Czarnecka W, Kaczmarczyk M, Liskiewicz P, Samochowiec J, Skonieczna-Zydecka K. | Front Microbiol | 10.3389/fmicb.2023.1125022 | 2023 | | |
| Spaceflight Modifies Escherichia coli Gene Expression in Response to Antibiotic Exposure and Reveals Role of Oxidative Stress Response. | Aunins TR, Erickson KE, Prasad N, Levy SE, Jones A, Shrestha S, Mastracchio R, Stodieck L, Klaus D, Zea L, Chatterjee A. | Front Microbiol | 10.3389/fmicb.2018.00310 | 2018 | | |
| Structural basis for activity switching in polymerases determining the fate of let-7 pre-miRNAs. | Yi G, Ye M, Carrique L, El-Sagheer A, Brown T, Norbury CJ, Zhang P, Gilbert RJC. | Nat Struct Mol Biol | 10.1038/s41594-024-01357-9 | 2024 | | |
| Treg-inducing capacity of genomic DNA of Bifidobacterium longum subsp. infantis. | Li D, Cheng J, Zhu Z, Catalfamo M, Goerlitz D, Lawless OJ, Tallon L, Sadzewicz L, Calderone R, Bellanti JA. | Allergy Asthma Proc | 10.2500/aap.2020.41.200064 | 2020 | | |
| Pathogenicity | Potent bactericidal action of a flavonoid fraction isolated from the stem bark of Butea frondosa. | Mishra US, Chakraborty P, Dasgupta A, Dastidar SG, Martins M, Amaral L. | In Vivo | 2009 | | |
| In-Vitro Antibacterial and Anti-Inflammatory Effects of Surfactin-Loaded Nanoparticles for Periodontitis Treatment. | Johnson A, Kong F, Miao S, Thomas S, Ansar S, Kong ZL. | Nanomaterials (Basel) | 10.3390/nano11020356 | 2021 | | |
| In vitro and in vivo antimicrobial action of tea: the commonest beverage of Asia. | Bandyopadhyay D, Chatterjee TK, Dasgupta A, Lourduraja J, Dastidar SG. | Biol Pharm Bull | 10.1248/bpb.28.2125 | 2005 | | |
| Pathogenicity | Amlodipine: a cardiovascular drug with powerful antimicrobial property. | Kumar KA, Ganguly K, Mazumdar K, Dutta NK, Dastidar SG, Chakrabarty AN. | Acta Microbiol Pol | 2003 | | |
| An Investigation on in vitro and in vivo Antimicrobial Properties of the Antidepressant: Amitriptyline Hydrochloride. | Mandal A, Sinha C, Kumar Jena A, Ghosh S, Samanta A. | Braz J Microbiol | 10.1590/s1517-83822010000300014 | 2010 | | |
| Detection of mutations in Salmonella enterica gyrA, gyrB, parC and parE genes by denaturing high performance liquid chromatography (DHPLC) using standard HPLC instrumentation. | Randall LP, Coldham NG, Woodward MJ. | J Antimicrob Chemother | 10.1093/jac/dki293 | 2005 | | |
| Structural elucidation of the O-antigenic polysaccharides from Escherichia coli O21 and the enteroaggregative Escherichia coli strain 105. | Staaf M, Urbina F, Weintraub A, Widmalm G. | Eur J Biochem | 10.1046/j.1432-1327.1999.00850.x | 1999 | | |
| Pathogenicity | Experimental analysis of antimicrobial action of dicyclomine hydrochloride. | Karaka P, Kumar KA, Basu LR, Dasgupta A, Ray R, Dastidar SG. | Biol Pharm Bull | 10.1248/bpb.27.2010 | 2004 | |
| Pathogenicity | Triflupromazine: a microbicide non-antibiotic compound. | Dastidar SG, Debnath S, Mazumdar K, Ganguly K, Chakrabarty AN. | Acta Microbiol Immunol Hung | 10.1556/amicr.51.2004.1-2.5 | 2004 | |
| Pathogenicity | Antibacterial potential of an antispasmodic drug dicyclomine hydrochloride. | Karak P, Kumar KA, Mazumdar K, Mookerjee M, Dastidar SG. | Indian J Med Res | 2003 | | |
| Pathogenicity | Antimicrobial potentiality of a phenothiazine group of antipsychotic drug-prochlorperazine. | Mazumder R, Chaudhuri SR, Mazumder A. | Indian J Exp Biol | 2002 | | |
| Pathogenicity | Trifluoperazine: a broad spectrum bactericide especially active on staphylococci and vibrios. | Mazumder R, Ganguly K, Dastidar SG, Chakrabarty AN. | Int J Antimicrob Agents | 10.1016/s0924-8579(01)00324-7 | 2001 | |
| Characterization of F18 fimbrial genes fedE and fedF involved in adhesion and length of enterotoxemic Escherichia coli strain 107/86. | Imberechts H, Wild P, Charlier G, De Greve H, Lintermans P, Pohl P. | Microb Pathog | 10.1006/mpat.1996.0053 | 1996 | | |
| Metabolism | Sex differences in the effects of adolescent stress on adult brain inflammatory markers in rats. | Pyter LM, Kelly SD, Harrell CS, Neigh GN. | Brain Behav Immun | 10.1016/j.bbi.2013.01.075 | 2013 | |
| Antibacterial activity of the antiinflammatory agent diclofenac sodium. | Annadurai S, Basu S, Ray S, Dastidar SG, Chakrabarty AN. | Indian J Exp Biol | 1998 | | ||
| Pathogenicity | Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United Kingdom. | Piddock LJ, Ricci V, McLaren I, Griggs DJ. | J Antimicrob Chemother | 10.1093/jac/41.6.635 | 1998 | |
| Studies on the existence of synergism between different antibiotics and a phenothiazine tranquilizer, promazine, possessing antimicrobial property. | Dastidar SG, Chakraborty P, Mookerjee M, Ganguly M, Chakrabarty AN. | Acta Microbiol Immunol Hung | 1994 | | ||
| Simple additives to increase the activity of chlorhexidine digluconate against urinary pathogens. | Harper WE. | Paraplegia | 10.1038/sc.1983.12 | 1983 | | |
| Etoposide (VP16) and teniposide (VM26): novel anticancer drugs, strongly mutagenic in mammalian but not prokaryotic test systems. | Gupta RS, Bromke A, Bryant DW, Gupta R, Singh B, McCalla DR. | Mutagenesis | 10.1093/mutage/2.3.179 | 1987 | | |
| Metabolism | New genetic regulators question relevance of abundant yolk protein production in C. elegans. | Van Rompay L, Borghgraef C, Beets I, Caers J, Temmerman L. | Sci Rep | 10.1038/srep16381 | 2015 | |
| Pathogenicity | Cell composition and drug resistance in Escherichia coli. | Hugo WB, Ellis JO. | Microbios | 1978 | | |
| Pathogenicity | Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium. | Piddock LJ, White DG, Gensberg K, Pumbwe L, Griggs DJ. | Antimicrob Agents Chemother | 10.1128/aac.44.11.3118-3121.2000 | 2000 | |
| Metabolism | The redox potential of growing cultures of Streptococcus bovis Orla-Jensen compared with other facultative anaerobes. | Wolstrup J, Chaudry SA, Jensen V. | Acta Vet Scand | 10.1186/bf03547592 | 1978 | |
| Pathogenicity | Effect of L. plantarum cell-free extract and co-trimoxazole against Salmonella Typhimurium: a possible adjunct therapy. | Rishi P, Preet S, Kaur P. | Ann Clin Microbiol Antimicrob | 10.1186/1476-0711-10-9 | 2011 | |
| Metabolism | Effect of glutaraldehyde on cell viability, triphenyltetrazolium reduction, oxygen uptake, and beta-galactosidase activity in Escherichia coli. | Munton TJ, Russell AD. | Appl Microbiol | 10.1128/am.26.4.508-511.1973 | 1973 | |
| Phylogeny | Kit systems for identifying gram negative aerobic bacilli: report of the Welsh Standing Specialist Advisory Working Group in Microbiology. | Bennett CH, Joynson DH. | J Clin Pathol | 10.1136/jcp.39.6.666 | 1986 | |
| Immunological specificity of natural opsonins and their role in the cross-reactivity between Staphylococcus aureus Mardi and Escherichia coli 101. | Young DA, Dobson P, Karakawa WW. | Infect Immun | 10.1128/iai.25.3.954-959.1979 | 1979 | | |
| Enzymology | Interaction of a new cephalosporin, 7-cyanacetamidocephalosporanic acid, with some gram-negative and gram-positive beta-lactamase-producing bacteria. | Russel AD. | Antimicrob Agents Chemother | 10.1128/aac.2.4.255 | 1972 | |
| Poly(N-acryloyl-4- and -5-aminosalicylic acids. II. Antibacterial properties and uses for the preparation of active, insoluble antibiotics. | Kennedy JF, Epton J, Kennedy GR. | Antimicrob Agents Chemother | 10.1128/aac.3.1.29 | 1973 | | |
| Active insolubilized antibiotics based on cellulose and cellulose carbonate. | Kennedy JF, Tun HC. | Antimicrob Agents Chemother | 10.1128/aac.3.5.575 | 1973 | | |
| Active immobilized antibiotics based on metal hydroxides. | Kennedy JF, Humphreys JD. | Antimicrob Agents Chemother | 10.1128/aac.9.5.766 | 1976 | | |
| Active insolubilized antibiotics based on cellulose-metal chelates. | Kennedy JF, Barker SA, Zamir A. | Antimicrob Agents Chemother | 10.1128/aac.6.6.777 | 1974 | | |
| Pathogenicity | Mode of action of the antibacterial compound dequalinium acetate. | Hugo WB, Frier M. | Appl Microbiol | 10.1128/am.17.1.118-127.1969 | 1969 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive4409.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License